Automate Your Wheel Strategy on MCK
With Tiblio's Option Bot, you can configure your own wheel strategy including MCK - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MCK
- Rev/Share 2867.8195
- Book/Share -13.5304
- PB -43.2067
- Debt/Equity -3.5632
- CurrentRatio 0.8993
- ROIC 0.2659
- MktCap 89398788960.0
- FreeCF/Share 44.8163
- PFCF 15.9328
- PE 27.1959
- Debt/Assets 0.0983
- DivYield 0.0048
- ROE -1.3273
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 2
- DCF Score 5
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Resumed | MCK | Mizuho | -- | Neutral | -- | $630 | Dec. 4, 2024 |
| Downgrade | MCK | Robert W. Baird | Outperform | Neutral | $603 | $531 | Sept. 24, 2024 |
| Reiterated | MCK | Leerink Partners | -- | Outperform | $670 | $665 | Sept. 5, 2024 |
News
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: July 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Read More
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Published: July 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Read More
Why McKesson (MCK) is a Top Value Stock for the Long-Term
Published: July 04, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?
Published: July 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
Here's Why McKesson (MCK) is a Strong Growth Stock
Published: July 03, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
McKesson (MCK) Stock Falls Amid Market Uptick: What Investors Need to Know
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Negative
McKesson (MCK) closed at $705.45 in the latest trading session, marking a -3.06% move from the prior day.
Read More
These Top 4 Women-Run Company Stocks Are Quietly Beating the Market
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Positive
These women-run company stocks offer high growth and stability.
Read More
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"
Published: July 01, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market.
Read More
5 Top-Ranked Dividend Growth Stock Picks for the Second Half of 2025
Published: June 30, 2025 by: Zacks Investment Research
Sentiment: Positive
AEM, NTES, QFIN, UGI and MCK stand out as strong dividend growth picks for steady income and upside in 2H25.
Read More
Calls of the Day: ServiceNow, S&P Global, McKesson Corp., Ross Stores, TJX and Burlington
Published: June 25, 2025 by: CNBC Television
Sentiment: Neutral
The Investment Committee debate the latest Calls of the Day.
Read More
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
Published: June 25, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
4 Stocks With Solid Shareholder Yield to Safeguard Your Portfolio
Published: June 23, 2025 by: Zacks Investment Research
Sentiment: Positive
MCK, LRCX, CTSH, and RITM stand out with strong shareholder yield, blending income, buybacks and debt reduction for portfolio defense.
Read More
Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?
Published: June 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Here is how McKesson (MCK) and Benitec Biopharma Limited (BNTC) have performed compared to their sector so far this year.
Read More
Here's Why McKesson (MCK) is a Strong Value Stock
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Why McKesson (MCK) is a Top Growth Stock for the Long-Term
Published: June 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
Published: June 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why
Published: June 03, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
Published: June 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Here is how McKesson (MCK) and Adagene Inc. Sponsored ADR (ADAG) have performed compared to their sector so far this year.
Read More
Why McKesson (MCK) is a Top Value Stock for the Long-Term
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Here's Why McKesson (MCK) is a Strong Momentum Stock
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
MCK vs. CAH: Which Drug Distribution Giant Has the Healthier Outlook?
Published: May 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Both McKesson and Cardinal Health dominate drug distribution, but which stock offers better growth and stability in 2025? Here we discuss which company has better long-term potential.
Read More
Is McKesson (MCK) a Buy as Wall Street Analysts Look Optimistic?
Published: May 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
MCK Stock Gains More Than 4% Following Strong Q4: Should You Buy Now?
Published: May 19, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson's MCK shares have gained 4.4% following its fourth-quarter fiscal 2025 earnings release on May 9. The post-earnings upside reflects growing investor confidence in McKesson's strategic execution and long-term positioning, underpinned by record full-year revenues of $359 billion and a 20% year-over-year increase in adjusted earnings per share (to $33.05).
Read More
McKesson To Spin-Off Its Medical-Surgical Solutions Business
Published: May 15, 2025 by: Forbes
Sentiment: Positive
Deal OverviewOn May 8, 2025, McKesson Corporation (NYSE: MCK, $682.28, Market Capitalization: $85.4 billion), a diversified healthcare services company, announced its intention to separate its Medical-Surgical Solutions segment into an independent company (NewCo) (for more information, visit spinoffresearch.com). McKesson is committed to exploring all opportunities to execute a separation in a manner that maximizes shareholder value and anticipates providing more information as appropriate on the form and timing as the process progresses.
Read More
3 Reasons Growth Investors Will Love McKesson (MCK)
Published: May 14, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market.
Read More
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Published: May 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
McKesson Corporation (MCK) CFO Britt Vitalone Hosts BofA Securities 2025 Healthcare Conference (Transcript)
Published: May 13, 2025 by: Seeking Alpha
Sentiment: Neutral
McKesson Corporation (NYSE:MCK ) BofA Securities 2025 Healthcare Conference May 13, 2025 11:00 AM ET Company Participants Britt Vitalone - Chief Financial Officer Conference Call Participants Allen Lutz - Bank of America Allen Lutz Welcome to day one of the BofA Healthcare Conference here in Las Vegas. We are very excited to welcome McKesson here.
Read More
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
Published: May 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
McKesson: Spinoff Of Medical-Surgical Solutions Is A Positive, Strong Buy
Published: May 09, 2025 by: Seeking Alpha
Sentiment: Positive
I reiterate a Strong Buy rating on McKesson Corporation with a fair value of $828 per share, driven by robust growth in the oncology and biopharma sectors. McKesson posted 19% revenue growth and 63.8% adj. EPS growth, largely driven by strong demand for GLP-1 products, which now represent 12% of total revenue. The company's global supply chain flexibility and non-discretionary drug pricing render it largely immune to tariff uncertainties, ensuring stable future growth.
Read More
About McKesson Corporation (MCK)
- IPO Date 1994-11-10
- Website https://www.mckesson.com
- Industry Medical - Distribution
- CEO Brian S. Tyler
- Employees 44000